It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
originally posted by: Char-Lee
originally posted by: worldwatcher
a reply to: Char-Lee
thanks Char- Lee
I really hope it's a hoax!!!!!! Because the implications of not being a hoax is frightening!!!!!!!
Yes me too, been reading and searching it does seem to be a hoax as far as the CDC being a source.
there are several different treatments being studied also.The trials have just started and some have not started yet
The early human tests are being conducted at the NIH Clinical Center in Bethesda, Md. The initial trial includes 20 adults, who received the vaccine in differing doses. Some results will likely come by year's end.
Are there other companies developing experimental treatments or vaccines?
Two other companies, Tekmira and Biocryst Pharmaceuticals, receive funding from the Department of Defense's Defense Threat Reduction Agency and have therapeutic candidates for Ebola in early development. The Department of Defense is working with a company called Newlink to develop an Ebola vaccine candidate. BioCryst, with NIH support, is working to develop an antiviral drug to treat Ebola virus that is expected to begin Phase 1 testing later this year.
ologists at the University of Liverpool have discovered how the plagues of the Middle Ages have made around 10% of Europeans resistant to HIV.
Scientists have known for some time that these individuals carry a genetic mutation (known as CCR5-delta 32) that prevents the virus from entering the cells of the immune system but have been unable to account for the high levels of the gene in Scandinavia and relatively low levels in areas bordering the Mediterranean.Source
Are you IMMUNE to EBOLA or AIDS? You might be.
September 23rd, 2014
You could be … About 10% of white people are Immune to AIDS C-C chemokine receptor type 5, also known as CCR5 or CD195, is a protein on the surface of white blood cells that is involved in the immune system as it acts as a receptor for chemokines. This is the process by which T cells are attracted to specific tissue and organ targets. Many forms of HIV, the virus that causes AIDS, initially use CCR5 to enter and infect host cells. A few individuals carry a mutation known as CCR5-Δ32 in the CCR5 gene, protecting them against these strains of HIV.
Ebola survivor Dr. Kent Brantly has again donated blood to help treat someone fighting the virus — this time a nurse who is the first person to contract the disease within the United States, a spokesman for Samaritan’s Purse told NBC News Monday. Brantly, who still works for the aid group, traveled to Dallas on Sunday to make the donation for Nina Pham, a nurse at Texas Health Presbyterian Hospital who helped to treat a Liberian man who died there last week, said Jeremy Blume, a spokesperson for Samaritan's Purse. [Source]